Edition:
United Kingdom

AVROBIO Inc (AVRO.OQ)

AVRO.OQ on NASDAQ Stock Exchange Global Select Market

20.18USD
18 Apr 2019
Change (% chg)

-- (--)
Prev Close
$20.18
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
56,114
52-wk High
$53.70
52-wk Low
$11.85

About

AVROBIO, Inc. is a clinical stage gene therapy company. The Company is focused on developing curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose. Its gene therapies employ hematopoietic stem cells that are extracted from the patient and then modified with lentiviral vectors to insert a... (more)

Overall

No Ratios Available.

Financials

  AVRO.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -- -- --
ROI: -- 8.91 13.83
ROE: -- 10.06 15.25

Earnings vs. Estimates